Navidea Biopharmaceuticals Inc
|Market Cap (Intraday)||55.73M|
|2yr Forward PE||N/A|
Navidea Biopharmaceuticals Inc Stock, ASE:NAVB
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.